INS and Alzheimer disease: ‐>To examine the effects of IN‐administered insulin on cognition, entorhinal cortex and hippocampal atrophy, and CSF biomarkers in amnestic MCI or mild AD over a 12‐month period‐>No cognitive or functional benefits were observed